Etoricoxib, CAS 202409-33-4

Etoricoxib, CAS 202409-33-4
Artikelnummer
CAY10091-100
Verpackungseinheit
100 mg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Shelf life (days): 1460.0

Formulation: A crystalline solid

Formal Name: 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine

Purity: ≥98%

Formula Markup: C18H15ClN2O2S

Formula Weight: 358.8

CAS Number: 202409-33-4

Notes: Etoricoxib is a dipyridinyl compound that demonstrates high in vitro and ex vivo selectivity for COX-2 over COX-1 in several assays, e.g., in the production of PGE2 by CHO cells expressing either COX-2 (IC50 = 79 nM) or COX-1 (IC50 > 50 µM).{11268,15425} Oral etoricoxib is well absorbed and metabolized extensively via oxidation, with metabolites excreted largely in the urine.{12837}
Mehr Informationen
Artikelnummer CAY10091-100
Hersteller Cayman Chemical
Hersteller Artikelnummer 10091-100
Verpackungseinheit 100 mg
Mengeneinheit STK
Produktinformation (PDF) Download
MSDS (PDF) Download